Trial Profile
Comparative study on the effects of calcium antagonists on central blood pressure.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Aug 2012
Price :
$35
*
At a glance
- Drugs Amlodipine (Primary) ; Azelnidipine (Primary)
- Indications Secondary hypertension
- Focus Therapeutic Use
- 23 Mar 2012 Actual end date (Jun 2011) added as reported by University Hospital Medical Information Network - Japan record.
- 23 Mar 2012 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
- 18 Mar 2011 New trial record